September 2026
The global shingles vaccine market size was exhibited at USD 6.57 billion in 2026 and is predicted to attain around USD 23.06 billion by 2035, with a CAGR of 15.02%.
September 2026
The neoantigen cancer vaccine market was worth USD 551.46 million in 2026, with key neoantigen cancer vaccine market players including Moderna Inc, BioNTech SE.
September 2026
The global oral vaccine market size was estimated at USD 4.64 billion in 2026 and is expected to surpass around USD 9.62 billion by 2034, with a CAGR of 9.53%.
September 2026
The global cancer vaccine market size was calculated at USD 11.32 billion in 2024 and is projected to hit around USD 33.38 billion by 2034 with a soild CAGR of 11.42%.
September 2026
The global respiratory disease vaccine market size was calculated at USD 103.17 billion in 2026 and is projected to hit around USD 123.77 billion by 2035 with a CAGR of 2.04%.
September 2026
The global vaccine adjuvants market size was estimated at USD 1.81 billion in 2026 and is projected to hit around USD 2.23 billion by 2035, with a CAGR of 2.34%.
September 2026
The global vaccine technologies market size is estimated to hit around USD 102.88 billion by 2035 increasing from USD 58.57 billion in 2026, with a CAGR of 6.46%.
September 2026
The global vaccine contract manufacturing market size is expected to increase to USD 12.26 billion by 2034 from USD 5.24 billion in 2026, with a CAGR of 11.20%.
September 2026
The pediatric vaccines market size was valued at USD 70.38 billion in 2026 and is expected to attain around USD 117.32 billion by 2035 with a CAGR of 5.86%.
September 2026
The meningococcal vaccine market was worth USD 4.28 billion in 2026, with key meningococcal vaccine market players including Pfizer Inc., Novartis AG, Bharat Biotech International Ltd., Janssen Pharmaceuticals, Inc.
September 2026
The influenza vaccine market size is expected to increase from USD 9.73 billion in 2026 and is expected to hit around USD 19.19 billion by 2035 with a CAGR of 7.84%.
September 2026
The global veterinary clostridium vaccine market size was evaluated at USD 1,030.76 billion in 2026 and is predicted to hit around USD 3,196.50 billion by 2035, growing at a CAGR of 13.40%.
September 2026
The global anthrax vaccine market size was evaluated at USD 14.84 billion in 2026 and is predicted to hit around USD 22.34 billion by 2035, growing at a CAGR of 4.65%.
September 2026
The global inactivated vaccines market size is estimated to hit around USD 79.02 billion by 2035 increasing from USD 45.44 billion in 2025, with a CAGR of 5.69%.
August 2026
The animal vaccine market generated USD 20.89 billion in 2026, with prominent truck platooning market companies including Triangle Merck & Co., Inc., Zoetis, Boehringer Ingelheim International GmbHÂ VirbacÂ
August 2026
The infectious disease vaccines market size reached USD 41.60 billion in 2026, with leading infectious disease vaccines market companies including Pfizer, Moderna, Johnson & Johnson (Janssen), GlaxoSmithKline (GSK).
July 2026
The global pneumococcal vaccines market size was evaluated at 9.04 billion in 2025 and is predicted to hit around USD 16.68 billion by 2035, growing at a CAGR of 6.32%.
June 2026
The global measles, mumps, rubella vaccine market size is estimated at USD 2.19 billion in 2026 and is expected to hit around USD 4.53 billion by 2035, growing at a CAGR of 8.41%.
June 2026
The global vaccine storage and packaging market size is estimated to hit around USD 39.24 billion by 2035 increasing from USD 24.55 billion in 2026, with a CAGR of 5.36%.
June 2026
The mRNA vaccines and therapeutics market size reached USD 116.88 billion in 2025 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
June 2026
The global adult vaccines market size was evaluated at USD 19.97 billion in 2025 and is predicted to hit around USD 50.39 billion by 2035, growing at a CAGR of 9.70%.
May 2026
The global vaccine delivery devices market size was evaluated at USD 8.06 billion in 2025 and is predicted to hit around USD 17.10 billion by 2035, growing at a CAGR of 7.81%.
April 2026
The global aquaculture vaccines market size is calculated at USD 553.40 million in 2025 and is projected to hit around USD 1,124.65 million by 2035 with a CAGR of 8.27% from 2026 to 2035.
April 2026
The global vaccines market size reached USD 91.97 billion in 2025 and is predicted to hit around USD 170.60 billion by 2035, growing at a notable CAGR of 6.37%.
February 2026
The global foot and mouth disease vaccine market size is expected to reach around USD 3.48 billion by 2035 from USD 1.94 billion in 2025 with a CAGR of 6.02%.
February 2026
The global brucellosis vaccines market size is valued at USD 266.78 million in 2025 and is expected to attain around USD 424.75 million by 2035 with a CAGR of 4.76%.
February 2026
The global canine vaccines market size was evaluated at USD 2.05 billion in 2025 and is predicted to hit around USD 4.23 billion by 2035, growing at a CAGR of 7.51%.
January 2026
The global human papillomavirus Hpv vaccines market size was evaluated at USD 9.73 billion in 2025 and is predicted to hit around USD 29.63 billion by 2035, growing at a CAGR of 11.78%.
December 2025
The global live attenuated vaccines market size is estimated at USD 35.73 billion in 2026 and is expected to hit around USD 82.63 billion by 2034, with a CAGR of 11.05%.
September 2025
The global vaccine CDMO market size was evaluated at USD 4.67 billion in 2024 and is predicted to hit around USD 11.16 billion by 2034, growing at a CAGR of 9.10%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com